Lifecare ASA will publish its Q2 2026 results on Wednesday, 19 August 2026, at
07:00 CEST.
The company invites shareholders, investors, and other stakeholders to the
presentation of the second quarter results the same day at 08.45 CEST, to be
held at Scandic Flesland Airport Hotel, Bergen, Norway, in connection with the
event Vestland på Børs.
The results will be presented in English via a live webcast, followed by a Q&A
session. Participants will be able to submit questions online throughout the
webcast.
The webcast will be available at
https://lifecare.no/investor/reports-presentations/ and can also be accessed
directly here (https://qcnl.tv/p/cs5yp_qSoQuYbeLPKsfJkA).
A recording of the webcast will be made available on our website shortly after
the event.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64
O\, petter.nielsen@lifecare.no\, +47 92 24 74 64\